Λέσχη Φίλων Στατιστικής - GrStats forum
Διάλεξη ΠΜΣ Βιοστατιστικής (Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ): Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness by M. Abrahamowicz Forumgrstats

Join the forum, it's quick and easy

Λέσχη Φίλων Στατιστικής - GrStats forum
Διάλεξη ΠΜΣ Βιοστατιστικής (Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ): Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness by M. Abrahamowicz Forumgrstats
Λέσχη Φίλων Στατιστικής - GrStats forum
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Για προβλήματα εγγραφής και άλλες πληροφορίες επικοινωνήστε με : grstats.forum@gmail.com ή grstats@stat-athens.aueb.gr

Go down
grstats
grstats
Posts : 934
Join date : 2009-10-21
http://stat-athens.aueb.gr/~grstats/

Διάλεξη ΠΜΣ Βιοστατιστικής (Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ): Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness by M. Abrahamowicz Empty Διάλεξη ΠΜΣ Βιοστατιστικής (Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ): Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness by M. Abrahamowicz

Mon 15 May 2017 - 12:55
ΠΜΣ Βιοστατιστικής - Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ

Διάλεξη

"Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness"


Michal Abrahamowicz

James McGill Professor of Biostatistics at McGill University, Montreal, Canada

Δευτέρα 15 Μαΐου 2017 15:00-16:00

Αίθουσα 2ου ορόφου

Εργαστηρίου Υγιεινής, Επιδημιολογίας και Ιατρικής Στατιστικής (Κτίριο 12) Ιατρική Σχολή, Μ. Ασίας 75, 11527 Γουδί

Σύντομο βιογραφικό του ομιλητή

Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has developed also new methods to control for different sources of bias in observational studies. His collaborative research includes arthritis, cardiovascular, and cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes >35 faculty members from 14 universities across Canada. He published >300 peer-reviewed papers, and supervised 19 PhD and 14 MSc students, and 7 post-doctoral fellows. He is the co-chair of the international STRATOS initiative. In 2010- 14 he was a member of the Executive Committee of ISCB.
Back to top
Permissions in this forum:
You cannot reply to topics in this forum